However, this subject would need further explorations because the prognostic value of such co-existing genetic alterations has been demonstrated in melanoma [9,25] and in other cancers (e.g., in non-small cell lung carcinoma harboring activating EGFR mutations [26,27]). This evidence concerns the gene EGFR and melanoma.